DUBLIN--(http://www.researchandmarkets.com/research/rrdcp2/global_rheumatoid) has announced the addition of the "Global Rheumatoid Arthritis Drug Pipeline Capsule - 2012 Update" report to their offering.)--Research and Markets (
“Global Rheumatoid Arthritis Drug Pipeline Capsule - 2012 Update”
Fore Pharma's latest report 'Global Rheumatoid Arthritis Drug Pipeline Capsule - 2012 Update' provides most up-to-date information on key Research and Development activities (R&D) in the global Rheumatoid Arthritis market. It covers active Rheumatoid Arthritis pipeline molecules in various stages of clinical trials, preclinical research, and drug discovery.
This report helps executives track competitors pipeline molecules. The information presented in this report can be used for identifying partners, evaluating opportunities, formulating business development strategies, executing in-licensing and out-licensing deals.
The report provides information on pipeline molecules by company and mechanism of action across the R&D stages. It also provides information on pipeline molecules developed in leading geographies (North America and Europe). Licensing activities are thoroughly captured in this report.
Key Features of the Report:
- Rheumatoid Arthritis: Overview
- Rheumatoid Arthritis Pipeline Overview
- Rheumatoid Arthritis Phase 3 Clinical Trial Pipeline Insights
- Rheumatoid Arthritis Phase 2 Clinical Trial Pipeline Insights
- Rheumatoid Arthritis Phase 1 Clinical Trial Pipeline Insights
- Rheumatoid Arthritis Preclinical Research Pipeline Insights
- Rheumatoid Arthritis Discovery Stage Pipeline Insights
- Geographic Landscape of Rheumatoid Arthritis R&D Activities
- Rheumatoid Arthritis R&D Activities in North America
- Rheumatoid Arthritis R&D Activities in Europe
- Licensing Activities / Partnerships
For more information visit http://www.researchandmarkets.com/research/rrdcp2/global_rheumatoid